GSK Capital B.V. Publication of Final Terms of EMTN Notes (6838H)
26 November 2022 - 03:47AM
UK Regulatory
TIDMGSK
RNS Number : 6838H
GSK Capital B.V.
25 November 2022
Issued: 25 November 2022, London UK - LSE Announcement
Publication of Final Terms
GSK Capital B.V. announces that the following final terms dated
25 November 2022 (the "Final Terms") in respect of the Notes (as
defined below) are available for viewing:
GSK Capital B.V. issue of:
EUR 500,000,000 3.000% Notes due 2027; and
EUR 750,000,000 3.125% Notes due 2032.
in each case guaranteed by GSK plc issued under the
GBP20,000,000,000 Euro Medium Term Note Programme (the "Notes")
Copies of the Final Terms have been submitted to the Financial
Conduct Authority's NSM submission portal via the Electronic
Submission System (ESS). A copy can be viewed at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
GSK plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
UK Media enquiries: Tim Foley +44 (0) 20 8047
5564
(London)
European Analyst/Investor Nick Stone +44 (0) 7717 618
enquiries: 834
(London)
James Dodwell
+44 (0) 7881 269
066
(London)
BASIS ON WHICH YOU MAY ACCESS THE FINAL TERMS AND PROSPECTUS
Please note that the information contained in the Final Terms
and the Prospectus may be addressed to and/or targeted at persons
who are residents of particular countries (specified in the
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Final Terms is not addressed. Prior to
relying on the information contained in the Final Terms or the
Prospectus you must ascertain from the Prospectus whether or not
you are part of the intended addressees of the information
contained therein.
Your right to access this service is conditional upon complying
with the above requirements.
GSK Capital B.V.
Registered in the Netherlands and in the UK as an overseas
company:
No. FC038264
Registered UK establishment:
980 Great West Road
Brentford, Middlesex
TW8 9GS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PFTBLBDBDSDDGDU
(END) Dow Jones Newswires
November 25, 2022 11:47 ET (16:47 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024